Clearsight Advises Kx Advisors in its Acquisition by BGB Group

Clearsight Advisors, Inc. (“Clearsight”) is pleased to announce another successful transaction in its Healthcare & Life Sciences Consulting practice. Clearsight served as the exclusive advisor to Kx Advisors, LLC (“Kx” or the “Company”) in its acquisition by BGB Group, LLC (“BGB”), a portfolio company of Tarrant Capital IP, LLC dba TPG (“TPG”).

Kx Advisors is a healthcare consultancy providing growth strategy services to leading pharmaceutical, biotechnology, and medical technology companies. With offices in Washington, DC, Boston, and London, the Kx team delivers data-driven analyses and global insights to develop holistic strategies for their clients. The Company’s key capabilities include corporate strategy and franchise planning, market expansion and forecasting, mergers and acquisitions advisory, new product planning, pricing and market access, and brand planning and launch strategy. BGB Group is an agency focused on healthcare advertising, medical communications, strategic consulting, and payer and market access. Together with the backing of TPG, Kx and BGB will bring together decades of experience helping top pharmaceutical and medical device companies achieve scientific and commercial success.

Bob Serrano, Managing Partner at Kx, commented on the transaction, “Clearsight’s dedication and nuanced understanding of the healthcare and life sciences sector sets them apart from other banks. With Clearsight’s guidance, we were able to better navigate this deal process and maximize value for our business and employees. As a result, we are pleased to embark on our new partnership with BGB and TPG, where we see tremendous strategic and cultural synergies.”

Brendan Curran, Director at Clearsight, remarked, “Kx has a history of delivering impactful solutions to clients and advancing possibilities in medical innovation strategy. They stand out amongst the increasingly competitive life sciences advisory landscape. With BGB and TPG, Kx joins a team that is well-positioned to expand its service offerings outside of the medical communications space. We are excited to witness all they accomplish together.”

Clearsight Director Tory Steel expanded, “It was fantastic to get to know the Kx team and form a deeper understanding of their strategic goals. Kx’s high standard of excellence across data-driven insights and client-centered services warranted a partner who could maintain the Company’s integrity while elevating its portfolio of capabilities and expanding its reach. We are thrilled Kx has found such a fit with BGB and TPG and look forward to watching them continue to innovate together.”

The Clearsight deal team included Joel Kallett, Brendan Curran, Tory Steel, Ethan Webster, George Lorenze, and Johnny Lindsey.